- NVAX +2.64%
Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
Yahoo Finance · 3 weeks ago
Open | 17.00 |
High | 17.81 |
Low | 16.82 |
Mkt Cap | 2.52B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 16.67 |
52 Wk. Low | 3.53 |
52 Wk. High | 23.86 |
Related stocks
Company in Gaithersburg, Maryland
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 93.86M | 15.90% ▲ |
Net Income | -147.55M | - |
Diluted EPS | -1.05 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.36 | - |
Q1 2024 | -$1.06 | -$1.05 |
Q4 2023 | -$0.45 | -$1.44 |
S&P 500^GSPC | 5,459.10+59.88 (+1.11%) |
Dow 30^DJI | 40,589.34+654.27 (+1.64%) |
Nasdaq^IXIC | 17,357.88+176.16 (+1.03%) |
3M CompanyMMM | 127.16+22.99% |
Dutch Bros Inc.BROS | 38.02+2.31% |
50.45+11.44% |